Trial
NCT00003821
Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Genzyme, a Sanofi Company
Collaborators
—
Condition
Endometrial Cancer
Intervention
aminopterin
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-09-18